ArticleContemporary clinical trials communications2020

A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan.

Paolo Chiodini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.